JPS62263468A - Ink composition and examination body for detecting glucose - Google Patents
Ink composition and examination body for detecting glucoseInfo
- Publication number
- JPS62263468A JPS62263468A JP61107870A JP10787086A JPS62263468A JP S62263468 A JPS62263468 A JP S62263468A JP 61107870 A JP61107870 A JP 61107870A JP 10787086 A JP10787086 A JP 10787086A JP S62263468 A JPS62263468 A JP S62263468A
- Authority
- JP
- Japan
- Prior art keywords
- glucose
- ink composition
- test
- weight
- indicator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 92
- 239000008103 glucose Substances 0.000 title claims abstract description 92
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 42
- 230000035945 sensitivity Effects 0.000 claims abstract description 20
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 15
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000011230 binding agent Substances 0.000 claims abstract description 13
- 239000003381 stabilizer Substances 0.000 claims abstract description 13
- 239000003125 aqueous solvent Substances 0.000 claims abstract description 8
- 239000006174 pH buffer Substances 0.000 claims abstract description 6
- 238000012360 testing method Methods 0.000 claims description 66
- 238000001514 detection method Methods 0.000 claims description 42
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- 235000010323 ascorbic acid Nutrition 0.000 claims description 12
- 229960005070 ascorbic acid Drugs 0.000 claims description 12
- 239000011668 ascorbic acid Substances 0.000 claims description 12
- 150000007933 aliphatic carboxylic acids Chemical group 0.000 claims description 9
- 235000014121 butter Nutrition 0.000 claims description 8
- 241000147041 Guaiacum officinale Species 0.000 claims description 7
- 102000004316 Oxidoreductases Human genes 0.000 claims description 7
- 108090000854 Oxidoreductases Proteins 0.000 claims description 7
- 229940091561 guaiac Drugs 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 13
- 108090000790 Enzymes Proteins 0.000 abstract description 13
- 229940088598 enzyme Drugs 0.000 abstract description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 108010015776 Glucose oxidase Proteins 0.000 abstract description 9
- 235000019420 glucose oxidase Nutrition 0.000 abstract description 8
- 239000004366 Glucose oxidase Substances 0.000 abstract description 7
- 230000008859 change Effects 0.000 abstract description 7
- 229940116332 glucose oxidase Drugs 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000011002 quantification Methods 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 86
- 238000003860 storage Methods 0.000 description 14
- 210000001124 body fluid Anatomy 0.000 description 13
- 239000010839 body fluid Substances 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 210000002700 urine Anatomy 0.000 description 10
- 239000007787 solid Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- -1 urine Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- 239000000123 paper Substances 0.000 description 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 238000007639 printing Methods 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 4
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229940035044 sorbitan monolaurate Drugs 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 2
- 239000004261 Ascorbyl stearate Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 235000019276 ascorbyl stearate Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000007646 gravure printing Methods 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Landscapes
- Inks, Pencil-Leads, Or Crayons (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
[産業上の利用分野1
本発明は、溶液特に尿などの体液中のブドウ糖を簡単且
つ迅速に検出しうる検査体を形成するのに適したインキ
組成物ならびにそれを用いて形成された検査体に関する
。
[従来の技術1
尿、血液或いはリンパ液などの体液中のブドウ′糖の吊
を迅速に且つ簡単に知ることは、’o尿病のψ期発見1
診断ならびに管理に必要不可欠である。
体液特に家中のブドウ糖を検出するには、従来主として
、ブドウ糖検査試薬が塗布された検査体が用いられてき
た。この検査体は、使用に際して操作が簡単でしかも判
定が短時間で行なえるという利点があった。
ところで体液中のブドウ糖検出用検査体では、ブドウ糖
酸化酵素の作用により、ブドウ糖は空気中の酸素と反応
して最終的にグルコン酸と過酸化水素に酸化される。こ
の過酸化水素は、ペルオキシダーゼの作用により発生期
の酸素を産生じ、この酸素は直ちにグアヤク脂、o−ト
リジン等の被酸化性指示薬と反応して該指示薬を発色さ
せる。
この原理を利用した体液中のブドウ糖検出用検査体は、
1g酸化酵素、ペルオキシダーゼ、被酸化性指示薬から
なる試薬組成物を水または水−アルコール系溶媒中に溶
解または分散させ、得られた液に口紙を含浸させた後、
乾燥し、この口紙をプラスチックフィルムに貼着し適宜
な大きさに裁断して作製されてきた。
ところがこの方法によれば、以下のような問題点があっ
た。
(a)糖酸化酵素、ペルオキシダーゼ、被酸化性指示薬
かうなる試薬組成物を水または水−アルコール系溶媒に
溶解或いは分散して含浸用液をFl製すると、酵素は不
安定で失活しやすく、しかも含浸用液は急速に変質して
しまう。このため含浸用液の調製後直ちに多工程にわた
る口紙の含浸を行なう必要がある。また、直ちに口紙の
含浸を行なっても、酵素の一部は失活し、また含浸用液
が一部変質してしまうという問題点があった。
(b)上述の如く、含浸用液は不安定でしかも製造工程
が複雑であるため、得られる検査体の品質を一定に保つ
ことが難しく、検査体の試験精度および信頼性を確保す
るためには、特別な注意と熟練が要求され、製造効率が
低下しやすく、製造コストの上昇を招いていた。
このため、製造工程を簡素化でき大量生産に適した検査
体の開発が進められ、特公昭44−25953号公報に
は、水−アルコール混合溶液に酵素類を予め溶解させ、
これに指示薬、pH緩衝剤、高分子結合剤、および吸水
性担体等を混合して、印刷またはコーティング適性を有
するインキ組成物をw4製し、このインキ組成物を支持
体上に印刷(コーティングを含む)した後乾燥して検査
体を製造する方法が提案されている。しかしながらこの
方法では、酵素類は一部水に溶解されており、従って不
安定で急速に失活するため、w4製後直ちに印刷を行な
う必要があった。その上酵素の失活を防止するため低温
で乾燥する必要があり、しかも長期保存性を得るために
、塗布された試薬層中の残留水分量をできるだけ少なく
する必要があった。
このような情況のもとで、本出願人は特開昭58−20
9995号公報において、酵素類を殆ど溶解しない非水
系溶媒に酵素類を分散させ、次いで更に指示薬、緩衝剤
、結合剤、および吸水性担体を溶解或いは分散させてイ
ンキ組成物を調製し、このインキ組成物を支持体上に印
刷して検査体を製造する方法を提案した。この方法によ
れば、ブドウ糖に対して優れた定量性能を示し且つ感度
も優れた検査体が得られるが、この検査体は大気中に長
時間さらしておくと徐々に呈色が不拘−且つ不鮮明とな
る傾向があり、また、検体中のブドウ糖濃度が低いうち
に高濃度の呈色が起り、飽和してしまうため、ごく低濃
度のブドウ糖を除いては定量が困難であった。このため
、体液を検査するに際して、誤った判定を下す恐れがあ
り、これら問題点に対する解決が強く望まれていた。[Industrial Application Field 1] The present invention relates to an ink composition suitable for forming a test body capable of easily and quickly detecting glucose in a solution, particularly a body fluid such as urine, and a test body formed using the ink composition. Regarding. [Prior art 1: Quickly and easily detecting glucose levels in body fluids such as urine, blood, or lymph fluid is useful for detecting the ψ stage of urinary disease 1
Essential for diagnosis and management. To detect glucose in body fluids, particularly in the home, test specimens coated with glucose test reagents have conventionally been used. This test specimen had the advantage of being easy to operate and allowing determination to be made in a short time. By the way, in a test sample for detecting glucose in body fluids, glucose reacts with oxygen in the air due to the action of glucose oxidase, and is finally oxidized to gluconic acid and hydrogen peroxide. This hydrogen peroxide produces nascent oxygen by the action of peroxidase, and this oxygen immediately reacts with an oxidizable indicator such as guaiac butter or o-tolidine to cause the indicator to develop color. A test sample for detecting glucose in body fluids using this principle is
After dissolving or dispersing a reagent composition consisting of 1 g of oxidase, peroxidase, and an oxidizable indicator in water or a water-alcoholic solvent, and impregnating a mouthpiece with the resulting liquid,
After drying, the opening paper is pasted onto a plastic film and cut to an appropriate size. However, this method has the following problems. (a) When a reagent composition consisting of sugar oxidase, peroxidase, and an oxidizable indicator is dissolved or dispersed in water or a water-alcoholic solvent to prepare an impregnating solution, the enzyme is unstable and easily deactivated. Moreover, the impregnating liquid deteriorates rapidly. For this reason, it is necessary to impregnate the opening paper in multiple steps immediately after preparing the impregnating liquid. Furthermore, even if the paper is impregnated immediately, there is a problem that some of the enzymes are deactivated and the impregnating liquid is partially deteriorated. (b) As mentioned above, since the impregnating liquid is unstable and the manufacturing process is complicated, it is difficult to maintain a constant quality of the test specimen obtained, and it is necessary to ensure the test accuracy and reliability of the test specimen. requires special care and skill, tends to reduce manufacturing efficiency, and increases manufacturing costs. For this reason, the development of test specimens that can simplify the manufacturing process and are suitable for mass production is progressing, and in Japanese Patent Publication No. 44-25953, enzymes are predissolved in a water-alcohol mixed solution.
An indicator, a pH buffer, a polymeric binder, a water-absorbing carrier, etc. are mixed with this to prepare an ink composition suitable for printing or coating, and this ink composition is printed (coated) on a support. A method has been proposed in which the test specimen is manufactured by drying the test specimen. However, in this method, the enzymes are partially dissolved in water and therefore unstable and rapidly deactivated, so it was necessary to print immediately after producing w4. Furthermore, it is necessary to dry at a low temperature to prevent deactivation of the enzyme, and furthermore, in order to obtain long-term storage stability, it is necessary to minimize the amount of residual moisture in the coated reagent layer. Under these circumstances, the present applicant filed the
No. 9995, an ink composition is prepared by dispersing enzymes in a nonaqueous solvent that hardly dissolves the enzymes, and then further dissolving or dispersing an indicator, a buffer, a binder, and a water-absorbing carrier. We proposed a method for manufacturing test specimens by printing a composition on a support. According to this method, a test specimen that exhibits excellent quantitative performance and sensitivity for glucose can be obtained, but when this test specimen is exposed to the atmosphere for a long time, the color gradually becomes unrestricted and unclear. In addition, high-concentration coloring occurs and becomes saturated while the glucose concentration in the sample is low, making it difficult to quantify except for very low concentrations of glucose. For this reason, when testing body fluids, there is a risk of incorrect judgment being made, and a solution to these problems has been strongly desired.
【発明が解決しようとする問題点1
本発明者らは上記問題点を解決するため研究した結果、
前述したブドウ糖検出用試験片における呈色の均−性並
びに鮮明性の低下は試薬組成物特にこの中に含まれる被
酸化性指示薬が大気中に微量に存在す・ろ過酸化物質等
の作用を受けることに起因することを見出した。そして
更に研究を重ねた結果、試薬組成物中に感度調節剤及び
安定剤を添加することにより検体中のブドウ″Is濃度
と呈色濃度との比例関係が改善され、ブドウ糖の低濃度
から高濃度にわたって直線的に呈色濃度が増加し、定量
が容易となり、呈色の均−性並びに鮮明性も良好となる
ことがわかった。更に被酸化性指示薬を適宜選択するこ
とにより、より好ましい結果の得られることが判明した
。
本発明は、従来技術に伴う欠点を解決しようとするもの
であって、以下のような目的を有している。
(a)優れた感度及び定量性能を有するブドウ糖検出体
を形成しうるインキ組成物並びにそれを用いて形成され
たブドウ糖検出体を提供すること。
(b)大気中に長時間にわたって保存しても安定であっ
て変色現象が認められないブドウ糖検出用インキ組成物
並びにそれを用いて形成されたブドウ糖検出体を提供す
ること。
(C) ill布法特に印刷法によって形成でき、従っ
て製造工程を簡素化しつるブドウ糖検出体を提供すると
共に、その形成に際して用いられるブドウ糖検出用イン
キ組成物を提供すること。
【問題点を解決するための手段】
本発明に係る体液中のブドウ糖検出用インキ組成物は、
糖酸化酵素、ペルオキシダーゼ、被酸化性指示薬、感度
調節剤、安定剤、 pH緩衝剤、結合剤、および吸水性
粉末からなる試薬組成物が、非水溶媒中に溶解或いは分
散されて形成されている。
また本発明に係るブドウ糖検出体は、上記組成のブドウ
糖検出用インキ組成物を支持体上に塗布してなるブドウ
糖検出領域を有している。
体液中のブドウ糖は、グルコースオキシダーゼ等のブド
ウ糖酸化酵素の作用により、空気中の酸素と反応して最
終的にグルコン酸と過酸化水素に酸化される。生成した
過酸化水素は、ペルオキシダーゼの作用により発生期の
酸素を産生じ、この酸素は直ちにグアヤク脂、0−トリ
ジン等の被酸化性指示薬と反応して該指示薬を発色させ
る。この発色の程度により、体液中のブドウ糖の有無並
びにその量が半定量的に決定される。
本発明に係る検査体を形成するに際して用いられるブド
ウ糖検出用インキ組成物を構成する各成分について以下
に詳細に説明する。
イ)糖酸化酵素
糖酸化酵素としてのグルコースオキシダーゼは、精製さ
れた凍・浩乾燥品の状態で用いられる。この酵素は、例
えば酵素活性が100 unit/ff1gの力価のも
のを用いた場合、インキ組成物の固形分に対して0.0
2〜2重量%好ましくは0.2〜1.8重量%の吊で存
在することが望ましい。
口)ペルオキシダーゼ
ペルオキシダーゼは、過酸化水素または有機過酸化物に
よる種々の有橢物の酸化を接触する酵素であって、主に
西洋ワサビから抽出される。この酵素は、例えば、活性
が100 unit/Rgの力価の凍結乾燥品を用いた
場合インキ組成物の固形分に対して0.002〜1重量
%好ましくは0.02〜0.2学吊%の吊で存在するこ
とが望ましい。
ハ)被酸化性指示薬
被酸化性指示薬は、酸素によって酸化されて発色する指
示薬であって、例えばベンジジン類及びN−アルキル化
ベンジジン類等の従来既知の化合物が広く用いられうる
が、このうちグアヤク脂。
0−トリジンが好ましく、その中でも特にグアヤク脂を
用いることが好ましい。被酸化性指示薬としてグアヤク
脂を使用し、更に後述の感度調部剤を併用することによ
り、一般に使用されるベンジジン誘導体を使用する場合
と比較してブドウ糖検出用インキ組成物並びにブドウ糖
検出用検査体の安全性、保存安定性、及び呈色安定性が
改良される。この被酸化性指示薬は、インキ組成物の固
形分に対して0.5〜10重量%好ましくは0.6〜6
重量%の吊で存在することが望ましい。
二)感度調節剤
本発明においては、感度調節剤としてアスコルビン酸の
脂肪族カルボン酸エステルを使用することにより、ブド
ウ糖検出用検査体の定量性、即ち、検体中に含まれるブ
ドウ糖濃度と検査試薬部の呈色濃度との直線性を改良す
ることができる。アスコルビン酸の脂肪族カルボン酸エ
ステルを添加しない場合は、検体中のブドウ糖濃度が低
いうちに高21:1度の呈色が起り、飽和してしまうた
め、ごく低濃度のブドウ糖を除いては定量が困難である
。
脂肪族カルボン酸としては、好ましくは飽和の総炭素数
CがC−C、特にC12〜C2゜の脂肪族飽和カルボン
酸が好ましいものとして挙げられる。
アスコルビン酸の低級カルボン酸エステルは水に溶は易
く、また、022以上のものは他成分との相溶性、WJ
剤への溶解性、重量に比しての感度調節効果の低いこと
等の理由により好ましくない。
感度調節剤の添加層はインキ組成物の固形分に対し′、
0.02〜5重量%が望ましい。
ホ)安 定 剤
安定剤は、糖酸化酵素、ペルオキシダーゼ、被酸化性指
示薬、感度調節剤、p■緩衝剤、結合剤。
及び吸水性粉末からなる試薬組成物の安定化に寄与する
ものである。このうち被酸化性指示薬は、前述の如く大
気中の過酸化物質等の作用を受けて変色する傾向が認め
られるが、これを防止するのが安定剤の主たる役割であ
る。上記感度調節剤であるアスコルビン酸の脂肪酸エス
テルは、安定剤としての作用も有している。アスコルビ
ン酸のような還元剤は、本検査の目的であるグルコース
検出の反応系、即ち、被酸化性指示薬の酸化反応を阻害
し、感度低下をきたす性質があるが、脂肪族カルボン酸
として、上記のように炭素数C1〜C3oの脂肪族飽和
カルボン酸を選択使用することにより、アスコルビン酸
の脂肪族カルボン酸エステルに起因する被酸化性指示薬
の呈色阻害を避けることができる。
従って、アスコルビン酸の脂肪族エステルを安定剤とし
て使用し、ブドウ糖検出用検査体の保存中における被酸
化性指示薬の酸化を防止することができるが、ブドウ糖
検出用インキ組成物の安定剤として公知の、抗酸化活性
を有する化合物またはグリセ0−ルエステル類に代表さ
れる特定の界面活性剤或いはこれらの混合物を適宜加え
ることもできる。これら安定剤の添加層は特に限定はさ
れないが、インキ組成物の固形分に対し0,02〜5重
量%が好ましい。
へ) all! m 剤
pHl1 l剤は、上記の被酸化性指示薬がブドウ糖検
出用インキ組成物中で好ましい呈色変化を起すpHの近
くのpH値を保つために用いられる。pea WiI剤
としては、所定のpH値(例えばpH5>をインキ組成
物に与えうるちのであれば何れのものでもよいが、具体
的にはクエン酸とクエン酸ナトリウムとの組合せが好ま
しく用いられる。
ト)結 合 剤
結合剤は、被検体液中の成分及びI)H等に影響を及ぼ
さず、且つ試薬類特に酵素並びに被酸化性指示薬に影響
を及ぼさず、しかも発色反応を妨げないものであること
が要求される。このような要件を満たすことが確かめら
れた結合剤としては、(I>ポリエステル樹脂、アルキ
ド樹脂、ポリウレタン樹脂、ポリスチレン樹脂9.アク
リル樹脂。
エポキシ樹脂、塩化ビニル樹脂、塩化ビニル共重合体4
1rl脂、ポリビニルブチラール樹脂、ポリビニルアル
コール樹脂、ポリビニルピロリドン樹脂。
無水マレイン酸系共重合体等の合成樹脂類、(I)メチ
ルセルロース、エチルセルロース、ヒドロキシエチルセ
ルロース、カルボキシメチルセルロース等のセルロース
誘導体、(II[)デンプン、多糖類、ゼラチン、カゼ
イン或いはアルギン酸ナトリウム等の天然高分子等が用
いられる。またこれらの結合剤を二種以上組合せてもよ
い。この結合剤はインキ組成物の固形分に対して0.1
〜20重量%好ましくは、0.5〜10重量%の吊で存
在することが望ましい。
チ)吸水性粉末
吸水性粉末の添加は、支持体上に設けられた試薬組成物
の吸水性を高め、被被体液と試薬組成物との接触が促進
され、指示薬の呈色反応を促進する働きを有する
このような吸水性粉末としては、水と接触した場合に、
極端な酸性或いはアルカリ性を示すものは好ましくなく
、しかも白色度の高いものが好ましい。具体的には、カ
オリン、合成シリカ、ガラス、セルロースブロック、微
結晶セルロース、イオン交換セルO−ス、イオン交換樹
脂、炭酸カルシウム、炭酸マグネシウム、ケイ酸アルミ
ニウム等が用いられうる。
吸水性粉末は、インキ組成物の固形分に対して30〜9
0重量%の量で存在することが好ましい。
す)非水溶媒
上記の各成分は、水を実質的に含むことのない非水溶媒
中に溶解或いは分散される。このような非水溶媒として
は、(a)ベンゼン、トルエン等の芳香族炭化水素、(
b)メチルエチルケトン等の詣肪族ケトン、(C)酢酸
エチル等のエステル類或いは(d) n−ブタノール等
のアルコール類等が用いられる。アルコール類のうち、
C〜C2の低級アルコールは8の失活を招くため好まし
くない。
非水溶媒は実質的に水を含まないことが好ましく、この
ため溶媒は使用前に脱水して用いることが好ましい。
ヌ)その他の成分
場合によっては、上記各成分のほかに、湿潤剤をブドウ
糖検出用インキ組成物中に配合できる。
湿潤剤としては、非イオン界面活性剤、陰イオン界面活
性剤、陽イオン界面活性剤9両性イオン界面活姓剤、ポ
リエチレングリコール類等が用いられ、この湿潤剤は、
各試薬の分散に役立ち均一な試薬層の形成を促進し、水
ぬれ性を向上させることができる。湿潤剤はインキ組成
物の固形分に対して0.5〜5重量%の吊で存在するこ
とが好ましい。
また、指示薬の呈色色調を更に見やすくするために、例
えばオイルイエロー等の背景色素を添加してもよい。
尚、上記のような組成を有するブドウ糖検出用インキ組
成物によりブドウ糖検出領域を形成して体液中のブドウ
糖を検出すると、被検体液中にアスコルビン酸、グルタ
チオン或いはシスティン等の還元物質が共存している場
合にも、これらの物質による呈色反応への悪影響が殆ど
認められないという利点もある。
上記のようなブドウ糖検出用インキ組成物は、支持体上
に塗布されてブドウ糖検出領域が形成され、本発明に係
る検査体が得られる。塗布技術としては、印刷法、コー
ティング法(例えばロールコーティング、スプレーコー
ティング、ディップコーティング、ベタコーティング)
等が用いられうる。本発明においては、インキ組成物の
塗布量が比較的多く且つ塗布量が一定であることが好ま
しいため、シルクスクリーン印刷法、凹版印刷法。
グラビア印刷法等によって、インキ組成物を支持体上に
設けることが好ましい。塗布量は、インキ組成物の種類
に応じて変化するが、一般に2〜150g/m<乾燥時
)であることが好ましい。
支持体は、試薬組成物と反応せずしかも試薬の呈色を阻
害しないものであることが好ましく、具体的には、例え
ば紙2合成紙、不織布または合成樹脂フィルム或いは紙
と合成樹脂フィルムとの積層体等が用いられる。
このような支持体上にブドウ糖検査領域が設けられた本
発明に係る検査体は、スティック状、ロール状、テープ
状等の形態に形成されていてもよい。或いは支持体自体
が被検体液を採取しつるような形態例えばコツプ状、試
験管状9皿状、トレイ状、スポイト状に形成され、その
支持体上にブドウ糖検査領域を設けて、本発明に係る検
査体としてもよい。
(実 施 例]
以下に本発明を実施例により説明するが、本発明はこれ
らの実施例に限定されるものではない。
実施例1
下記組成のブドウ糖検出用インキ」酸物をホモミキサー
で微細分散させた後、スクリーン印刷により、厚さ30
0μの白色ポリスチレンシートに一辺が5Mの四角形と
なるように印刷した。用いたスクリーン版は80メツシ
ユ、レジスト及びスクリーン紗の厚さの合計は130μ
であった。
ブドウ糖検出用インキ組成物
ブドウWM化酵素(東洋紡製; Grade fl )
3.6 重量部
ペルオキシダーゼ(東洋紡製; Grade m >2
.4 重量部
グアヤク脂 4.8 重量部ソ
ルビタンモノラウレート
(花王石鹸製;スパン20 ) 7.2 重
量部し一アスコルビルステアレー1〜0.48重承部ク
エン酸 2.8 重量部クエン
酸ナトリウム 11.Offlffi部ポリ
ビニルピロリドン
(BASF製;コリトン90) 12.6
重量部ポリビニルブチラール
(積水化学製:エスレックBX−1) 2.25重量
部セルロース微粉末
(層化成製:アビセルSF) 171 重量
部n−アミルアルコール 228 重量部ブ
チルセロソルブアセテート 33.5 11部得られ
た印刷物を60℃で40分間乾燥後、スティック状に裁
断してブドウ糖検出用検査体を得た。
正常尿及び正常尿にβ−D−グルコースを50q/dl
、 100I#g/旧、250■/ d + 、
500q/旧、及び2000ay/旧の濃度になるよう
に溶解したものを検体として用い、スティックを浸漬後
直ちに取出して1分間静置し、検査試薬部の色調を観察
した。
検査試薬部の呈色は均−且つ鮮°明であり、呈色濃度は
検体中のブドウ1!laI度の増加に伴って段階的に高
くなり、上記の範囲内で検体中のブドウ糖濃度を明確に
判別可能であった。呈色した検査体を室温で5分間静置
しても色調の変化は認められなかった。
得られた検査体をガラス容器中に密封し、40℃で12
ケ月間保存した後、上記と同様にして試験を行ったとこ
ろ、検査試薬部の呈色は保存前と同様に均一、鮮明、且
つ安定であり、検体中のブト91g濃度も保存前と同様
に明確に判別可能であった。
比較例1
実施例1に示したし一アスコルビルステアレートを使用
しない以外は実施例1と同様のブドウ糖検出用インキ組
成物を用い、実施例1と同様にしてブドウ糖検出用検査
体を得た。
正常尿及び正常尿にβ−D−グルコースを5ormg/
旧、 100q/旧、 250IRy/旧、 5
0h+y/旧、及び2000q / d Iの濃度にな
るように溶解したものを検体として用い、スティックを
浸漬後直ちに取出して1分間静置し、検査試薬部の色調
を観察した。
検査試薬部の呈色は実施例1と同様に均一、鮮明。
且つ安定であった。しかしながら検体中のブドウ糖濃度
が50■/diから250IRy/dlの範囲では、呈
色濃度はブドウ糖濃度の増加に伴って急激に高くなり、
且つ検体中のブドウ糖濃度が250I#g/ d lか
ら20007IIF / d Iの範囲では、呈色濃度
はブドウ糖濃度の増加に伴って徐々に高くなり、上記の
範囲内で検体中のブドウ糖濃度を明確に判別することは
困難であった。
また、得られた検査体をガラス容器中に密封し、40℃
で6ケ月間保存した後、上記と同様にして試験を行った
ところ、保存前と比較して検査試薬部の呈色は不拘−且
つ不鮮明となり、検体中のブドウ糖31度の判別も困難
であった。
実施例2
下記組成のブドウ糖検出用インキ組成物を用い、実施例
1と同様にしてブドウ糖検出用検査体を僻だ。
ブドウ糖検出用インキ組成物
ブドウ糖酸化酵素(東洋紡製: Grade II )
3.6 重量部
ペルオキシダーゼ(東洋紡製; Grade M )2
.4 重量部
グアヤク脂 4.8 重量部ソル
ビタンモノラウレート
(花王石鹸¥Jニスパン20)7.2 重量部し一ア
スコルビルパルミテート 0.48 fflffl部ク
エン酸 2.8 重量部クエン
酸ナトリウム 11.OII部メチルビニル
エーテル/無無水
−イン酸共重合体(G、 A、 F社製:ガントレッツ
AN−169)の7ミル
アルコールエステル化物 7.0 重量部セル
ロース微粉末
(脂化成製;アビセルSF) 171 重量
部n−アミルアルコール 228 重量部プ
チルセOソルブアセテート 33.5 重量部正常
尿及び正常尿にβ−D−グルコースを501#g/dl
、 100119/dl、 250IRg/dl、 5
00IIlil/dl、 及び2000119/旧の濃
度になるように溶解したものを検体として用い、スティ
ックを浸漬後直ちに取出して1分間静置し、検査試薬部
の色調を観察した。
検査試薬部の呈色は均−且つ鮮明であり、呈色した検査
体を室温で5分間静置しても色調の変化は認められなか
った。また、呈色濃度は実施例1と同様に検体中のブド
ウ糖濃度の増加に伴って段階的に高くなり、検体中のブ
ドウ糖濃度の判別が可能であった。
得られた検査体をガラス容器に密封し、40°Cで12
ケ月間保存した後、上記と同様にして試験を行ったとこ
ろ、検査試薬部の呈色は保存前と同僅に均一、鮮明、且
つ安定であった。
比較例2
実施例2に示したし一アスコルビルパルミテートを使用
しない以外は実施例2と同様のブドウ糖検出用インキ組
成物を用いて、実施例2と同様にしてブドウ糖検出用検
査体を得た。
実施例2と同様にして調製した検体を用い、スティック
を浸漬後直ちに取出して1分間静置し、検査試薬部の色
調を観察した。検査試薬体の呈色は均−且つ鮮明であり
、呈色した検査体を室温で5分間静置しても色調の変化
は認められなかった。
しかしながら比較例1に記載のように検体中のブドウ糖
濃度の判別は困難であった。
得られた検査体をガラス容器に密封し、40℃で6ケ月
間保存した後、上記と同様にして試験を行ったところ、
保存前と比較して検査試薬部の呈色は不拘−且つ不鮮明
となった。
実施例3
下記組成のブドウ糖検出用インキ組成物を用い、実施例
1と同様にしてブドウ糖検出用検査体を得た。
ブドウ糖検出用インキ組成物
ブドウ糖酸化酵素(東洋紡製; Grade ■)3.
6 重Φ部
ペルオキシダーゼ(東洋紡製; Grade II[)
2.4 重量部
0−トリジン 10.0 重量部ソ
ルビタンモノラウレート
(花王石鹸製ニスパン20)7.2 重量部し一アス
コルビルステアレート 0.5 重量部クエンM
2.8 重■部クエン酸ナトリ
ウム 11.Offlffl部メチルビニル
エーテル/無水マ
レイン酸共重合体(G、 A、 F社製;ガントレッツ
へN−169)のアミル
アルコールエステル化物 7.0 重量部セル
ロース微粉末
(脂化成製:アビセルSF) R7重量部n−
7ミルアルコール 228 重量部ブチルセ
ロソルブアセテート 33.5 重量部正常尿及び
正常尿にβ−D−グルコースを50ffig/dl、
1100I1/dl、 250IRg/dl、 500
1g/dl、及び2000■/diの濃度になるように
溶解したものを検体として用い、スティックを浸漬後直
ちに取出して1分間静置し、検査試薬部の色調を観察し
た。
検査試薬部の呈色は均−且つ鮮明であり、呈色濃度は検
体中のブドウ糖濃度の増加に伴って段階的に高くなり、
上記の範囲内でブドウ糖濃度を明確に判別可能であった
。呈色した検査体を至瀉で1分間静置すると、呈色濃度
が顕著に低くなった。
得られた検査体をガラス容器に密封し、40℃で6ケ月
間保存した後、上記と同様にして試験を行ったところ、
検査試薬部の呈色は保存前とfi;J 祿に均一、鮮明
、且つ安定であり、検体中のブドウ糖濃度も保存前と同
様に明確に判別可能であった。
比較例3
下記組成のブドウ糖検出用インキ組成物を用い、実施例
1と同様にしてブドウ゛糖検出用検査体を青た。
ブドウ糖検出用インキ組成物
ブドウ糖酸化酵素(東洋紡製; Grade ■)3.
6重量部
ペルオキシダーゼ(東洋紡製; Grade l[)2
.4重塁部
o−トリジン io、o重量部ソル
ビタンモノラウレート
(花玉石υ製;スパン20)7.2重量部クエン酸
2.8重量部クエン酸ナトリウ
ム 11.Oli部メデメチルビニルエー
テル/
無水イン酸共重合体<GAF社製;
ガントレッツへN−169)のアミル
アルコールエステル化物 7.0重量部セルロ
ース微粉末
(連化成製;アビセルSF) 171重吊承
部−アミルアルコール 228重量部ブチル
セロソルブアセテート 33.5重量部実施例3と
同様にして調製した検体を用い、スティックを81漬後
直ちに取出して1分間静置し、検査試薬部の色調を観察
した。浸漬液から取出した直後の検査試薬部の呈色は均
−且つ鮮明であったが、呈色した検査体を室温で1分間
静ばすると呈色濃度が顕著に低くなった。
検体中のブドウU濃度が501#g/ d +から25
0q/d1の範囲では、呈色濃度はブドウI!i濃度の
増加に伴って急激に高くなり、且つ検体中のブドウ糖濃
度が250q / d Iから2000/IjiF/旧
の範囲では、呈色濃度はブドウ糖濃度の増加に伴って徐
々に高くなり、上記の範囲内で検体中のブドウ糖濃度を
明確に判別することは困難であった。
得られた検査体をガラス容器に密封し、40℃で1ケ月
間保存した後、上記と同様にして試験を行ったところ、
保存前と比較して検査試薬部の呈色は顕著に不均一かつ
不鮮明となった。[Problem to be solved by the invention 1] As a result of the inventors' research to solve the above problems,
The decrease in color uniformity and sharpness in the above-mentioned glucose detection test strip is caused by the presence of trace amounts of the oxidizable indicator in the reagent composition, especially the oxidizable indicator contained therein, which is affected by filtration oxidizing substances, etc. I found out that this is due to this. As a result of further research, by adding a sensitivity regulator and a stabilizer to the reagent composition, the proportional relationship between the concentration of grape 'Is in the sample and the color density was improved, and the concentration of glucose from low to high concentration was improved. It was found that the color density increases linearly over time, quantification becomes easier, and the color uniformity and sharpness are also good.Furthermore, by appropriately selecting the oxidizable indicator, more favorable results can be obtained. The present invention seeks to solve the drawbacks associated with the prior art and has the following objects: (a) glucose detection with excellent sensitivity and quantitative performance; To provide an ink composition capable of forming a body and a glucose detector formed using the same. (b) An ink composition for glucose detection that is stable even when stored in the atmosphere for a long time and does not cause discoloration. To provide an ink composition and a glucose detector formed using the ink composition. To provide an ink composition for detecting glucose in body fluids according to the present invention.
A reagent composition consisting of a sugar oxidase, peroxidase, an oxidizable indicator, a sensitivity regulator, a stabilizer, a pH buffer, a binder, and a water-absorbing powder is dissolved or dispersed in a non-aqueous solvent. . Further, the glucose detector according to the present invention has a glucose detection area formed by coating a glucose detection ink composition having the above composition on a support. Glucose in body fluids reacts with oxygen in the air through the action of glucose oxidases such as glucose oxidase, and is finally oxidized to gluconic acid and hydrogen peroxide. The generated hydrogen peroxide produces nascent oxygen by the action of peroxidase, and this oxygen immediately reacts with an oxidizable indicator such as guaiac butter or O-tolidine to cause the indicator to develop color. Based on the degree of color development, the presence or absence of glucose in the body fluid and its amount are determined semi-quantitatively. Each component constituting the ink composition for glucose detection used in forming the test object according to the present invention will be described in detail below. B) Glucose oxidase Glucose oxidase as a sugar oxidase is used in the form of a purified freeze-dried product. For example, when this enzyme is used with a titer of 100 units/ff1g, the enzyme activity is 0.0% based on the solid content of the ink composition.
It is desirable to be present in an amount of 2 to 2% by weight, preferably 0.2 to 1.8% by weight. Peroxidase Peroxidase is an enzyme that oxidizes various minerals with hydrogen peroxide or organic peroxide, and is mainly extracted from horseradish. For example, when a freeze-dried product with a titer of 100 units/Rg is used, this enzyme is present in an amount of 0.002 to 1% by weight, preferably 0.02 to 0.2% by weight based on the solid content of the ink composition. It is desirable that it be present in the range of %. C) Oxidizable Indicator The oxidizable indicator is an indicator that develops color when oxidized by oxygen, and conventionally known compounds such as benzidines and N-alkylated benzidines can be widely used. Fat. O-tolidine is preferred, and among these, it is particularly preferred to use guaiac butter. By using guaiac butter as an oxidizable indicator and also using a sensitivity adjusting agent described below, the ink composition for glucose detection and the test material for glucose detection are more effective than when using a commonly used benzidine derivative. Safety, storage stability, and color stability are improved. The oxidizable indicator is preferably 0.5 to 10% by weight based on the solid content of the ink composition, preferably 0.6 to 6% by weight.
Preferably, it is present in weight percentages. 2) Sensitivity regulator In the present invention, by using an aliphatic carboxylic acid ester of ascorbic acid as a sensitivity regulator, it is possible to improve the quantitative properties of a test sample for glucose detection, that is, the glucose concentration contained in the sample and the test reagent portion. It is possible to improve linearity with color density. If an aliphatic carboxylic acid ester of ascorbic acid is not added, a high 21:1 coloration occurs while the glucose concentration in the sample is low and becomes saturated, making it difficult to quantify except for very low concentrations of glucose. is difficult. Preferred examples of the aliphatic carboxylic acids include aliphatic saturated carboxylic acids having a total number of saturated carbon atoms of CC, particularly C12 to C2°. Lower carboxylic acid esters of ascorbic acid are easily soluble in water, and those with 022 or higher are compatible with other components, WJ
It is not preferred due to its solubility in agents and its low sensitivity adjustment effect compared to its weight. The added layer of the sensitivity modifier is based on the solid content of the ink composition',
0.02 to 5% by weight is desirable. e) Stabilizer Stabilizers include sugar oxidase, peroxidase, oxidizable indicator, sensitivity regulator, p■ buffer, and binder. and contributes to stabilizing the reagent composition consisting of the water-absorbing powder. Among these, oxidizable indicators have a tendency to change color due to the action of peroxides in the atmosphere, as described above, and the main role of the stabilizer is to prevent this. The fatty acid ester of ascorbic acid, which is the sensitivity regulator, also functions as a stabilizer. Reducing agents such as ascorbic acid have the property of inhibiting the reaction system for glucose detection, which is the purpose of this test, that is, the oxidation reaction of the oxidizable indicator, resulting in a decrease in sensitivity. By selectively using an aliphatic saturated carboxylic acid having a carbon number of C1 to C3o, it is possible to avoid coloration inhibition of the oxidizable indicator caused by the aliphatic carboxylic acid ester of ascorbic acid. Therefore, it is possible to use an aliphatic ester of ascorbic acid as a stabilizer to prevent oxidation of the oxidizable indicator during storage of a glucose detection specimen. , a compound having antioxidant activity, a specific surfactant typified by glycerol esters, or a mixture thereof may be added as appropriate. The layer to which these stabilizers are added is not particularly limited, but preferably 0.02 to 5% by weight based on the solid content of the ink composition. to) all! The agent pH11 is used to maintain a pH value close to the pH at which the oxidizable indicator causes a preferable color change in the ink composition for detecting glucose. The pea WiI agent may be any agent as long as it can impart a predetermined pH value (for example, pH 5>) to the ink composition, and specifically, a combination of citric acid and sodium citrate is preferably used. G) Binding agent The binding agent should be one that does not affect the components in the sample body fluid and I)H, etc., and does not affect the reagents, especially enzymes and oxidizable indicators, and does not interfere with the color reaction. something is required. Binders that have been confirmed to meet these requirements include (I> polyester resins, alkyd resins, polyurethane resins, polystyrene resins; 9. acrylic resins; epoxy resins, vinyl chloride resins, vinyl chloride copolymers; 4.
1rl resin, polyvinyl butyral resin, polyvinyl alcohol resin, polyvinylpyrrolidone resin. Synthetic resins such as maleic anhydride copolymers, (I) Cellulose derivatives such as methylcellulose, ethylcellulose, hydroxyethylcellulose, and carboxymethylcellulose, (II) Natural polymers such as starch, polysaccharides, gelatin, casein, or sodium alginate. etc. are used. Furthermore, two or more of these binders may be combined. This binder is 0.1% based on the solid content of the ink composition.
It is desirable to be present in an amount of ~20% by weight, preferably 0.5-10% by weight. H) Water-absorbing powder Addition of the water-absorbing powder increases the water absorption of the reagent composition provided on the support, promotes contact between the target liquid and the reagent composition, and promotes the coloring reaction of the indicator. Such a water-absorbing powder that has the function of:
Those exhibiting extreme acidity or alkalinity are not preferred, and those with high whiteness are preferred. Specifically, kaolin, synthetic silica, glass, cellulose block, microcrystalline cellulose, ion exchange cell O-su, ion exchange resin, calcium carbonate, magnesium carbonate, aluminum silicate, etc. can be used. The water-absorbing powder has a content of 30 to 9 based on the solid content of the ink composition.
Preferably it is present in an amount of 0% by weight. B) Non-aqueous solvent Each of the above components is dissolved or dispersed in a non-aqueous solvent that does not substantially contain water. Examples of such non-aqueous solvents include (a) aromatic hydrocarbons such as benzene and toluene;
b) Aliphatic ketones such as methyl ethyl ketone, (C) esters such as ethyl acetate, or (d) alcohols such as n-butanol are used. Among alcohols,
C-C2 lower alcohols are not preferred because they lead to deactivation of 8. It is preferable that the non-aqueous solvent does not substantially contain water, and therefore it is preferable that the solvent is dehydrated before use. n) Other components In addition to the above-mentioned components, a humectant may be added to the glucose detection ink composition depending on the case. As wetting agents, nonionic surfactants, anionic surfactants, cationic surfactants, zwitterionic surfactants, polyethylene glycols, etc. are used, and these wetting agents include:
It helps in dispersing each reagent, promotes the formation of a uniform reagent layer, and improves water wettability. The wetting agent is preferably present in an amount of 0.5 to 5% by weight based on the solids content of the ink composition. Further, in order to make the color tone of the indicator more visible, a background dye such as oil yellow may be added. Note that when a glucose detection area is formed using the glucose detection ink composition having the composition described above to detect glucose in a body fluid, reducing substances such as ascorbic acid, glutathione, or cysteine coexist in the body fluid. There is also the advantage that, even when these substances are present, there is hardly any adverse effect on the color reaction caused by these substances. The glucose detection ink composition as described above is applied onto a support to form a glucose detection area, thereby obtaining a test object according to the present invention. Application techniques include printing methods, coating methods (e.g. roll coating, spray coating, dip coating, solid coating)
etc. can be used. In the present invention, since it is preferable that the amount of the ink composition applied is relatively large and constant, silk screen printing method and intaglio printing method are used. Preferably, the ink composition is provided on the support by a gravure printing method or the like. The coating amount varies depending on the type of ink composition, but is generally preferably 2 to 150 g/m<dry. The support is preferably one that does not react with the reagent composition and does not inhibit the coloring of the reagent, and specifically, for example, paper 2 synthetic paper, nonwoven fabric, synthetic resin film, or a combination of paper and synthetic resin film. A laminate or the like is used. The test body according to the present invention, in which a glucose test area is provided on such a support, may be formed into a stick shape, a roll shape, a tape shape, or the like. Alternatively, the support itself may be formed into a shape capable of collecting the body fluid to be tested, such as a pot shape, a test tube shape, a tray shape, or a dropper shape, and a glucose test area may be provided on the support body, according to the present invention. It may also be used as a test object. (Example) The present invention will be explained below with reference to Examples, but the present invention is not limited to these Examples. Example 1 Glucose detection ink having the following composition. After dispersing, the thickness is 30 mm by screen printing.
It was printed on a 0μ white polystyrene sheet so that each side was a 5M square. The screen plate used was 80 mesh, and the total thickness of the resist and screen gauze was 130μ.
Met. Ink composition for glucose detection Grape WM convertase (manufactured by Toyobo; Grade fl)
3.6 parts by weight peroxidase (manufactured by Toyobo; Grade m >2
.. 4 parts by weight Guaac butter 4.8 parts by weight Sorbitan monolaurate (manufactured by Kao Soap; Span 20) 7.2 parts by weight 1 to 0.48 parts by weight citric acid 2.8 parts by weight Sodium citrate 11. Offfffi part Polyvinylpyrrolidone (manufactured by BASF; Koliton 90) 12.6
Parts by weight Polyvinyl butyral (Sekisui Chemical Co., Ltd.: S-LEC BX-1) 2.25 parts by weight Cellulose fine powder (Kyakasei Co., Ltd.: Avicel SF) 171 Parts by weight n-amyl alcohol 228 Parts by weight Butyl cellosolve acetate 33.5 11 parts obtained The printed matter was dried at 60° C. for 40 minutes and then cut into sticks to obtain test pieces for glucose detection. 50q/dl of β-D-glucose in normal urine and normal urine
, 100I#g/old, 250■/d+,
The sticks were dissolved to concentrations of 500q/old and 2000ay/old, and the sticks were taken out immediately after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The color of the test reagent part is uniform and bright, and the color density is 1! It increased stepwise as the laI degree increased, and the glucose concentration in the sample could be clearly determined within the above range. No change in color tone was observed even when the colored specimen was allowed to stand at room temperature for 5 minutes. The obtained specimen was sealed in a glass container and heated at 40°C for 12
After storage for several months, a test was conducted in the same manner as above, and the color of the test reagent was uniform, clear, and stable as before storage, and the concentration of buto-91g in the sample was the same as before storage. It was clearly distinguishable. Comparative Example 1 A test specimen for glucose detection was obtained in the same manner as in Example 1 using the same ink composition for glucose detection as in Example 1 except that the ascorbyl stearate shown in Example 1 was not used. Normal urine and normal urine with β-D-glucose at 5ormg/
Old, 100q/old, 250IRy/old, 5
The sticks were dissolved to a concentration of 0h+y/old and 2000q/dI and used as specimens, and the sticks were taken out immediately after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The coloration of the test reagent part was uniform and clear as in Example 1. Moreover, it was stable. However, when the glucose concentration in the sample is in the range of 50 μ/di to 250 IRy/dl, the color density increases rapidly as the glucose concentration increases.
In addition, when the glucose concentration in the sample is in the range of 250I#g/dl to 20007IIF/dI, the color density gradually increases as the glucose concentration increases, and the glucose concentration in the sample can be clearly determined within the above range. It was difficult to distinguish. In addition, the obtained specimen was sealed in a glass container and heated to 40°C.
After storage for 6 months, a test was conducted in the same manner as above, and the color of the test reagent part became unrestricted and unclear compared to before storage, and it was difficult to distinguish the 31% glucose in the sample. Ta. Example 2 A specimen for glucose detection was prepared in the same manner as in Example 1 using the ink composition for glucose detection having the composition shown below. Ink composition for glucose detection Glucose oxidase (manufactured by Toyobo: Grade II)
3.6 Parts by weight Peroxidase (manufactured by Toyobo; Grade M) 2
.. 4 parts by weight Guaiac butter 4.8 parts by weight Sorbitan monolaurate (Kao Soap ¥J Nispan 20) 7.2 parts by weight Ascorbyl palmitate 0.48 parts by weight Citric acid 2.8 parts by weight Sodium citrate 11. Part OII: 7 methyl alcohol ester of methyl vinyl ether/anhydride-inic acid copolymer (manufactured by G, A, F companies: Gantrez AN-169) 7.0 parts by weight Cellulose fine powder (manufactured by Fukaisei; Avicel SF) 171 Parts by weight n-amyl alcohol 228 Parts by weight Putilce O-solve acetate 33.5 Parts by weight Normal urine and β-D-glucose in normal urine 501#g/dl
, 100119/dl, 250IRg/dl, 5
00IIlil/dl and 2000119/old were used as specimens, and the sticks were taken out immediately after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The coloration of the test reagent portion was uniform and clear, and no change in color tone was observed even when the colored test specimen was left standing at room temperature for 5 minutes. Furthermore, as in Example 1, the color density increased stepwise as the glucose concentration in the sample increased, making it possible to discriminate the glucose concentration in the sample. The obtained specimen was sealed in a glass container and incubated at 40°C for 12
After storage for several months, a test was conducted in the same manner as above, and the coloration of the test reagent portion was as uniform, clear, and stable as before storage. Comparative Example 2 A test specimen for glucose detection was obtained in the same manner as in Example 2 using the same glucose detection ink composition as in Example 2 except that ascorbyl palmitate was not used. . Using a sample prepared in the same manner as in Example 2, the stick was taken out immediately after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The coloration of the test reagent body was uniform and clear, and no change in color tone was observed even when the colored test body was allowed to stand at room temperature for 5 minutes. However, as described in Comparative Example 1, it was difficult to determine the glucose concentration in the sample. The obtained specimen was sealed in a glass container and stored at 40°C for 6 months, and then tested in the same manner as above.
Compared to before storage, the coloration of the test reagent part became unrestricted and unclear. Example 3 A test specimen for glucose detection was obtained in the same manner as in Example 1 using an ink composition for glucose detection having the following composition. Ink composition for glucose detection Glucose oxidase (manufactured by Toyobo; Grade ■) 3.
6 Heavy Φ peroxidase (manufactured by Toyobo; Grade II [)
2.4 Parts by weight 0-Tolidine 10.0 Parts by weight Sorbitan monolaurate (Nispan 20 manufactured by Kao Soap) 7.2 Parts by weight Ascorbyl stearate 0.5 Parts by weight Citrus M
2.8 Heavy Sodium Citrate 11. Offflffl part: Amyl alcohol ester of methyl vinyl ether/maleic anhydride copolymer (manufactured by G, A, F companies; Gauntletz N-169) 7.0 parts by weight Cellulose fine powder (manufactured by Fukaisei: Avicel SF) R7 parts by weight n-
7 mil alcohol 228 parts by weight Butyl cellosolve acetate 33.5 parts by weight Normal urine and β-D-glucose in normal urine 50ffig/dl,
1100I1/dl, 250IRg/dl, 500
The sample was dissolved to a concentration of 1 g/dl and 2000 ml/di, and the stick was taken out immediately after immersion, left to stand for 1 minute, and the color tone of the test reagent portion was observed. The coloration of the test reagent part is uniform and clear, and the color density increases stepwise as the glucose concentration in the sample increases.
It was possible to clearly determine the glucose concentration within the above range. When the colored specimen was allowed to stand still for 1 minute, the color density decreased significantly. The obtained specimen was sealed in a glass container and stored at 40°C for 6 months, and then tested in the same manner as above.
The coloration of the test reagent portion was uniform, clear, and stable compared to before storage, and the glucose concentration in the sample was also clearly distinguishable as before storage. Comparative Example 3 A test specimen for glucose detection was colored blue in the same manner as in Example 1 using the ink composition for glucose detection having the composition shown below. Ink composition for glucose detection Glucose oxidase (manufactured by Toyobo; Grade ■) 3.
6 parts by weight peroxidase (manufactured by Toyobo; Grade l[)2
.. 4 parts o-tolidine io, o parts by weight Sorbitan monolaurate (manufactured by Hanatamaishi υ; Span 20) 7.2 parts by weight citric acid
2.8 parts by weight sodium citrate 11. Oli part: Medemethyl vinyl ether/indic acid anhydride copolymer <manufactured by GAF; Gauntletz N-169) amyl alcohol esterified product 7.0 parts by weight Cellulose fine powder (manufactured by Renkasei; Avicel SF) 171 Heavy suspension part - Amyl alcohol: 228 parts by weight Butyl cellosolve acetate: 33.5 parts by weight Using a specimen prepared in the same manner as in Example 3, the stick was immediately taken out after soaking for 81 minutes, left to stand for 1 minute, and the color tone of the test reagent portion was observed. Immediately after taking out the test reagent from the immersion liquid, the coloration of the test reagent portion was uniform and clear, but when the colored test sample was allowed to stand at room temperature for 1 minute, the color density decreased significantly. Grape U concentration in the sample is from 501#g/d+ to 25
In the range of 0q/d1, the color density is Grape I! When the concentration of glucose in the sample ranges from 250q/dI to 2000/IjiF/Old, the color concentration gradually increases as the concentration of glucose increases, and the above It was difficult to clearly determine the glucose concentration in the sample within this range. The obtained specimen was sealed in a glass container and stored at 40°C for one month, and then tested in the same manner as above.
Compared to before storage, the coloration of the test reagent part became noticeably uneven and unclear.
本発明に係るブドウ糖検出用インキ組成物及びそれを用
いて形成された検査体は、感度調製剤としてアスコルビ
ン酸の脂肪族カルボン酸エステルを使用することにより
、上記実施例に記載したように、ブドウ糖検出用検査体
の定量性の改善、即ち、検体中に含まれるブドウ糖濃度
と検査試薬部の呈色濃度との比例関係が改善され、検体
中のブドウ糖の低濃度から高濃度にわたって、直線的に
呈色m度が増加し、定量が容易となる。比較例に記載の
ように7スコルビン酸の脂肪族カルボン酸エステルを添
加しない場合は、検体中のブドウ糖濃度が低いうちに高
濃度の呈色が起り、ブドウ糖濃度が高い範囲での呈色変
化は極めて僅かであるので極く低濃度のブドウ糖濃度を
除いては定量が困難である。また、アスコルビン酸の脂
肪族カルボン酸エステルは安定剤としての効果も有する
ので、ブドウ糖検出用インキ組成物、及び該検査体を大
気中に長時間に旦って保存しても安定であって、変色現
象が認められない。また、本発明によるブドウ糖検出用
検査体は、支持体上に直接塗布法、特に印刷法によりブ
ドウ糖検出領域が形成出来るため、大量生産に適してお
り、製造工程も簡略化することが出来る。The ink composition for glucose detection according to the present invention and the specimen formed using the same can be used to detect glucose as described in the above Examples by using an aliphatic carboxylic acid ester of ascorbic acid as a sensitivity adjusting agent. Improvement in the quantitative performance of the detection test sample, that is, the proportional relationship between the glucose concentration in the sample and the color density of the test reagent part has been improved, and the glucose concentration in the sample can be linearly measured from low to high concentrations. The degree of color development increases, making quantitative determination easier. As described in the comparative example, when the aliphatic carboxylic acid ester of 7-scorbic acid is not added, a high concentration of coloration occurs while the glucose concentration in the sample is low, and no color change occurs in the range of high glucose concentration. Since the amount is extremely small, it is difficult to quantify except at extremely low glucose concentrations. In addition, since the aliphatic carboxylic acid ester of ascorbic acid also has the effect as a stabilizer, it is stable even when the ink composition for glucose detection and the test specimen are stored in the atmosphere for a long time. No discoloration phenomenon is observed. Furthermore, the glucose detection test body according to the present invention is suitable for mass production, and the manufacturing process can be simplified, since the glucose detection region can be formed on the support by direct coating, especially by printing.
Claims (6)
、感度調節剤、安定剤、pH緩衝剤、結合剤、および吸
水性粉末からなる試薬組成物が、非水溶剤中に溶解或い
は分散されてなることを特徴とするブドウ糖検出用イン
キ組成物。(1) A reagent composition consisting of a sugar oxidase, peroxidase, an oxidizable indicator, a sensitivity regulator, a stabilizer, a pH buffer, a binder, and a water-absorbing powder is dissolved or dispersed in a non-aqueous solvent. An ink composition for glucose detection characterized by the following.
エステルであることを特徴とする特許請求の範囲第1項
に記載のブドウ糖検出用インキ組成物。(2) The ink composition for glucose detection according to claim 1, wherein the sensitivity regulator is an aliphatic carboxylic acid ester of ascorbic acid.
する特許請求の範囲第1項に記載のブドウ糖検出用イン
キ組成物。(3) The ink composition for glucose detection according to claim 1, wherein the oxidizable indicator is guaiac butter.
、感度調節剤、安定剤、pH緩衝剤、結合剤、および吸
水性粉末からなる試薬組成物が、非水溶剤中に溶解或い
は分散されてなるブドウ糖検出用インキ組成物を支持体
上に塗布してなるブドウ糖検出用検査体。(4) A reagent composition consisting of a sugar oxidase, peroxidase, an oxidizable indicator, a sensitivity regulator, a stabilizer, a pH buffer, a binder, and a water-absorbing powder is dissolved or dispersed in a non-aqueous solvent. A test body for detecting glucose, which is obtained by applying an ink composition for detecting glucose onto a support.
エステルであることを特徴とする特許請求の範囲第4項
に記載のブドウ糖検出用検査体。(5) The test material for glucose detection according to claim 4, wherein the sensitivity regulator is an aliphatic carboxylic acid ester of ascorbic acid.
する特許請求の範囲第4項に記載のブドウ糖検出用検査
体。(6) The test material for glucose detection according to claim 4, wherein the oxidizable indicator is guaiac butter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61107870A JPH0718881B2 (en) | 1986-05-12 | 1986-05-12 | Ink composition for glucose detection and test body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61107870A JPH0718881B2 (en) | 1986-05-12 | 1986-05-12 | Ink composition for glucose detection and test body |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62263468A true JPS62263468A (en) | 1987-11-16 |
JPH0718881B2 JPH0718881B2 (en) | 1995-03-06 |
Family
ID=14470171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61107870A Expired - Lifetime JPH0718881B2 (en) | 1986-05-12 | 1986-05-12 | Ink composition for glucose detection and test body |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0718881B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0510195A1 (en) * | 1989-12-25 | 1992-10-28 | Daiki Co., Ltd | Sheet, seat, bag, article of daily use, ink and packaging material for animal |
-
1986
- 1986-05-12 JP JP61107870A patent/JPH0718881B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0510195A1 (en) * | 1989-12-25 | 1992-10-28 | Daiki Co., Ltd | Sheet, seat, bag, article of daily use, ink and packaging material for animal |
Also Published As
Publication number | Publication date |
---|---|
JPH0718881B2 (en) | 1995-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5183742A (en) | Test device for detecting glucose, protein urobilinogen, and/or occult blood in body fluids and/or determining the PH thereof | |
US4260393A (en) | Method and combined test elements for detection of heme | |
JPS60178356A (en) | Body fluid tester | |
US4273868A (en) | Color stable glucose test | |
JPS6021454A (en) | Test composition for measuring peroxide activating substance, testing tool and measuring method thereof and manufacture thereof | |
JPS61122568A (en) | Test composition for measuring glucose in high-concentrationregion made to be contained in aqueous test sample in semi-determination manner, testing tool and preparation of testing | |
US4291121A (en) | Bilirubin-resistant determination of uric acid and cholesterol | |
JPS60178358A (en) | Glucose detecting ink composition and tester formed by using the same | |
JPS62263468A (en) | Ink composition and examination body for detecting glucose | |
JPH0328199B2 (en) | ||
CA1134247A (en) | Bilirubin-resistant determination of uric acid | |
JPS60178362A (en) | Ph measuring ink composition and tester formed by using the same | |
JP2811742B2 (en) | Sugar content measurement ink composition and test object | |
JPS62263469A (en) | Humor examination body and its preparation | |
JPS61284661A (en) | Inspecting body for detecting grape sugar | |
JPS61247967A (en) | Inspecting material for detecting grape sugar and its production | |
JP2532866B2 (en) | Inspection test paper | |
JPS62263466A (en) | Humor examination body | |
JP2640945B2 (en) | Peroxidatively active substance detection composition and test body | |
JP2610460B2 (en) | Occult blood detection composition and test body using the same | |
JP3521435B2 (en) | Glucose test ink composition and test sheet using the same | |
JPH03103194A (en) | Testing agent and testing tool | |
JPH0349695A (en) | Printing ink composition for detecting glucose and testing unit for detecting blood glucose using the same | |
JPH01193374A (en) | Ink composition and test specimen for measuring sugar content | |
JPS63184060A (en) | Examination test paper |